Indoor and outdoor air pollutants, from biomass smoke to common cleaning products, have extensive impact on respiratory ...

For recently diagnosed pulmonary arterial hypertension (PAH), adding sotatercept (Winrevair) to standard care lowered the ...

Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in ...

Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary ...

Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.

Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension ...

A woman bruising her leg with a massage gun set off a medical odyssey that revealed scurvy, a disease seen fairly rarely in ...

In December 2020, AEW star Brodie Lee passed away of pulmonary fibrosis at 41 years old, with his death resulting in a wave ...

A wearable device combined with machine learning may offer a solution for continuous cough monitoring in pulmonary fibrosis patients. A wearable cough monitor generated clinically useful cough data, ...

MSD has announced positive Phase III HYPERION trial results showing Winrevair (sotatercept-csrk) reduced clinical worsening ...

Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension ...

After a diagnosis of idiopathic pulmonary fibrosis at 78, Houghton Hutcheson continues to live his life and chooses not to ...